Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Evaluating the Effect of a Novel Web-based Intervention to Increase HIV Testing in Men Who Have Sex With Men (TuNexo)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
NGO Via Libre
Information provided by (Responsible Party):
Magaly Blas, Universidad Peruana Cayetano Heredia
ClinicalTrials.gov Identifier:
NCT01760057
First received: December 28, 2012
Last updated: November 19, 2013
Last verified: November 2013
  Purpose

The proposed study is designed to develop and test the effectiveness of a novel web-based HIV intervention to motivate HIV testing among men who have sex with men (MSM). The intervention arm includes the delivery of videos tailored to the reasons MSM have for not getting tested for HIV, as well as HIV testing motivational messages sent via mobile-phone text messaging, e-mail or instant messaging. The intervention and assessments will be guided by the Information-Motivation-Behavioral skills model, the Health Belief Model and the Stages of Change theory. The control intervention will be a health promotion message (similar in content to other Peruvian websites) with an invitation for free HIV testing. Testing will be offered at the Via Libre and Epicentro clinic, and at a mobile unit whose location will be determined based on participants' demand. The outcomes evaluated will be intention to get tested and actual HIV testing among MSM of each of the trial arms.


Condition Intervention
HIV Testing
Behavioral: Online HIV testing motivational videos and messages sent via mobile-phone text messaging, e-mail or instant messaging
Behavioral: Standard online message with an invitation for free HIV testing similar in content to other Peruvian websites

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Screening
Official Title: Randomized Controlled Trial to Evaluate the Effect of a Novel Web-based Intervention to Increase HIV Testing in Men Who Have Sex With Men in Lima-Peru

Resource links provided by NLM:


Further study details as provided by Universidad Peruana Cayetano Heredia:

Primary Outcome Measures:
  • HIV testing [ Time Frame: 6 months after been exposed to the intervention ] [ Designated as safety issue: No ]

Estimated Enrollment: 400
Study Start Date: January 2013
Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Placebo Comparator: Health promotion message
Standard online message with an invitation for free HIV testing similar in content to other Peruvian websites
Behavioral: Standard online message with an invitation for free HIV testing similar in content to other Peruvian websites
Experimental: Combined Web-based HIV intervention
Online HIV testing motivational videos and messages sent via mobile-phone text messaging, e-mail or instant messaging
Behavioral: Online HIV testing motivational videos and messages sent via mobile-phone text messaging, e-mail or instant messaging

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • be 18 years of age or older,
  • be a man and report having had sex with a man within the last 12 months,
  • be a resident of metropolitan Lima, Peru,
  • have not been tested for HIV within the last 12 months,
  • have a valid e-mail address,
  • do not report being HIV positive.

Exclusion Criteria:

  • Do not meet the inclusion criteria specified above
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01760057

Locations
Peru
Universidad Peruana Cayetano Heredia
Lima, Peru
Sponsors and Collaborators
Universidad Peruana Cayetano Heredia
NGO Via Libre
Investigators
Principal Investigator: Magaly M Blas, MD, PhD Universidad Peruana Cayetano Heredia
  More Information

Publications:
Responsible Party: Magaly Blas, Research professor, Universidad Peruana Cayetano Heredia
ClinicalTrials.gov Identifier: NCT01760057     History of Changes
Other Study ID Numbers: R01TW008398
Study First Received: December 28, 2012
Last Updated: November 19, 2013
Health Authority: Peru: Institutional Review Board of the Universidad Peruana Cayetano Heredia
Peru: Institutional Review Board of the Non-governmental Organization Via Libre

Additional relevant MeSH terms:
HIV Antibodies
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs

ClinicalTrials.gov processed this record on November 19, 2014